NASDAQ : ALLR
Allarity Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.8704 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 13.85M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Allarity Therapeutics, Inc. (ALLR) reported revenue of 345.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 345.00K | 320.00K | ||||
| Revenue | 345.00K | 320.00K | ||||
| Gross Profit | 345.00K | 320.00K | ||||
| Selling, General & Admin | 5.62M | 6.32M | 11.44M | 10.03M | 9.96M | 12.36M |
| Research & Development | 6.35M | 7.43M | 6.89M | 7.90M | 7.64M | 14.20M |
| Other Operating Expenses | -833.00K | -833.00K | -798.00K | -800.00K | -711.00K | |
| Operating Expenses | 11.14M | 12.93M | 17.54M | 17.13M | 16.89M | 26.56M |
| Operating Income | -10.79M | -12.61M | -17.54M | -17.13M | -16.89M | -26.56M |
| Interest Expense | -1.06M | -185.00K | -653.00K | -498.00K | -223.00K | -586.00K |
| Interest & Investment Income | 722.00K | 801.00K | 533.00K | 22.00K | 30.00K | |
| Currency Exchange Gain (Loss) | -1.07M | 757.00K | -212.00K | 133.00K | -913.00K | -95.00K |
| Other Non Operating Income (Expenses) | -128.00K | 1.00K | 2.68M | 5.65M | 17.12M | 353.00K |
| EBT Excluding Unusual Items | -12.33M | -11.23M | -15.19M | -11.82M | -873.00K | -26.88M |
| Gain (Loss) on Sale of Investments | -115.00K | -495.00K | ||||
| Gain (Loss) on Sale of Assets | 1.78M | 1.00M | ||||
| Asset Writedown | -9.70M | -17.57M | ||||
| Other Unusual Items | -800.00K | -141.00K | ||||
| Pretax Income | -12.33M | -11.23M | -24.90M | -11.82M | -17.58M | -26.52M |
| Income Tax Expense | -381.00K | 83.00K | -1.52M | 133.00K | ||
| Earnings From Continuing Operations | -12.33M | -11.23M | -24.52M | -11.90M | -16.06M | -26.65M |
| Net Income | -12.33M | -11.23M | -24.52M | -11.90M | -16.06M | -26.65M |
| Preferred Dividends & Other Adjustments | 639.00K | 8.52M | 4.99M | |||
| Net Income to Common | -12.33M | -11.23M | -25.15M | -20.42M | -21.05M | -26.65M |
| Shares Outstanding (Basic) | 15.67M | 14.38M | 1.61M | |||
| Shares Outstanding (Diluted) | 15.67M | 14.38M | 1.61M | |||
| EPS (Basic) | -0.79 | -0.78 | -15.65 | |||
| EPS (Diluted) | -0.79 | -0.78 | -15.65 | |||
| Free Cash Flow | -13.78M | -14.83M | -17.65M | -12.74M | -16.84M | -14.89M |
| Free Cash Flow Per Share | -0.88 | -1.03 | -10.98 | |||
| Gross Margin | 100.00% | 100.00% | ||||
| Operating Margin | -3,128.99% | -3,939.06% | ||||
| Profit Margin | -3,575.07% | -3,509.69% | ||||
| Free Cash Flow Margin | -3,994.78% | -4,633.75% | ||||
| EBITDA | -10.80M | -12.60M | -17.53M | -17.09M | -16.83M | -26.45M |
| D&A For EBITDA | -6.00K | 9.00K | 9.00K | 37.00K | 60.00K | 106.00K |
| EBIT | -10.79M | -12.61M | -17.54M | -17.13M | -16.89M | -26.56M |
| Revenue as Reported | 345.00K | 320.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 16.98M | 14.69M | 19.53M | 166.00K | 2.03M | 19.55M |
| Short-Term Investments | 83.00K | 72.00K | 56.00K | 51.00K | 403.00K | |
| Cash & Short-Term Investments | 16.98M | 14.77M | 19.61M | 222.00K | 2.08M | 19.96M |
| Other Receivables | 1.31M | 895.00K | 2.23M | 946.00K | 871.00K | 1.34M |
| Receivables | 1.31M | 895.00K | 2.23M | 946.00K | 871.00K | 1.34M |
| Prepaid Expenses | 3.38M | 2.11M | 507.00K | 781.00K | 591.00K | 36.00K |
| Other Current Assets | 61.00K | 153.00K | 22.00K | 1.43M | 65.00K | |
| Total Current Assets | 31.73M | 17.93M | 22.34M | 1.97M | 4.97M | 21.40M |
| Property, Plant & Equipment | 386.00K | 330.00K | 309.00K | 20.00K | 27.00K | 94.00K |
| Other Intangible Assets | 9.87M | 9.55M | 28.14M | |||
| Total Assets | 32.12M | 18.26M | 22.65M | 11.86M | 14.54M | 49.63M |
| Accounts Payable | 4.11M | 4.28M | 4.18M | 8.42M | 6.25M | 698.00K |
| Accrued Expenses | 1.48M | 2.52M | 2.46M | 1.25M | 1.90M | 8.59M |
| Short-Term Debt | 20.86M | 2.64M | ||||
| Current Portion of Long-Term Debt | 1.42M | 1.40M | 1.35M | 1.30M | ||
| Current Portion of Leases | 8.00K | 98.00K | ||||
| Current Income Taxes Payable | 81.00K | 81.00K | 74.00K | 59.00K | 41.00K | 60.00K |
| Other Current Liabilities | 623.00K | 146.00K | 2.77M | 3.14M | 374.00K | 11.27M |
| Total Current Liabilities | 28.58M | 8.43M | 10.84M | 14.17M | 11.22M | 20.72M |
| Long-Term Debt | 1.08M | 979.00K | ||||
| Long-Term Leases | 9.00K | |||||
| Long-Term Deferred Tax Liabilities | 446.00K | 349.00K | 1.96M | |||
| Other Long-Term Liabilities | 7.18M | |||||
| Total Liabilities | 28.58M | 8.43M | 10.84M | 14.61M | 12.65M | 30.85M |
| Common Stock | 3.00K | 3.00K | 1.00K | 1.00K | ||
| Additional Paid-In Capital | 144.68M | 144.23M | 131.13M | 90.37M | 83.16M | 85.24M |
| Retained Earnings | -136.35M | -130.20M | -118.97M | -94.45M | -82.55M | -66.49M |
| Treasury Stock | -3.45M | -3.19M | ||||
| Comprehensive Income & Other | -1.35M | -1.02M | -354.00K | -411.00K | -721.00K | -600.00K |
| Total Common Equity | 3.54M | 9.83M | 11.81M | -4.49M | -113.00K | 18.15M |
| Shareholders' Equity | 3.54M | 9.83M | 11.81M | -2.75M | 1.89M | 18.78M |
| Total Liabilities & Equity | 32.12M | 18.26M | 22.65M | 11.86M | 14.54M | 49.63M |
| Total Debt | 22.29M | 1.40M | 1.35M | 1.30M | 3.73M | 1.09M |
| Net Cash (Debt) | -5.30M | 13.37M | 18.25M | -1.08M | -1.66M | 18.87M |
| Net Cash Per Share | -0.34 | 0.93 | 11.36 | |||
| Filing Date Shares Outstanding | 15.91M | 15.82M | 17.01M | 10.30K | 36.00 | 11.00 |
| Total Common Shares Outstanding | 15.91M | 19.03M | 7.30M | 19.00 | 10.00 | |
| Working Capital | 3.15M | 9.50M | 11.50M | -12.20M | -6.25M | 685.00K |
| Book Value Per Share | 0.22 | 0.52 | 1.62 | -5,947.37 | 1,815,200.00 | |
| Tangible Book Value | 3.54M | 9.83M | 11.81M | -14.36M | -9.66M | -9.98M |
| Tangible Book Value Per Share | 0.22 | 0.52 | 1.62 | -508,526.32 | -998,300.00 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -12.33M | -11.23M | -24.52M | -11.90M | -16.06M | -26.65M |
| Depreciation & Amortization | -28.00K | -13.00K | 9.00K | 37.00K | 60.00K | 106.00K |
| Other Amortization | 87.00K | |||||
| Loss (Gain) From Sale of Assets | -1.78M | -1.00M | ||||
| Asset Writedown & Restructuring Costs | 9.70M | 17.57M | ||||
| Loss (Gain) From Sale of Investments | 115.00K | 495.00K | ||||
| Stock-Based Compensation | 777.00K | 682.00K | 407.00K | -71.00K | 1.75M | 6.37M |
| Other Operating Activities | 2.36M | 1.42M | -3.02M | -4.16M | -18.15M | 141.00K |
| Change in Accounts Payable | -1.74M | -1.14M | -4.11M | 2.17M | 6.21M | -1.31M |
| Change in Unearned Revenue | 207.00K | |||||
| Change in Income Taxes | 7.00K | 15.00K | 18.00K | -19.00K | 8.00K | |
| Change in Other Net Operating Assets | -3.04M | -4.45M | 3.90M | 1.20M | -6.52M | 6.87M |
| Operating Cash Flow | -13.71M | -14.82M | -17.35M | -12.74M | -16.82M | -14.89M |
| Capital Expenditures | -72.00K | -8.00K | -298.00K | -18.00K | ||
| Sale of Property, Plant & Equipment | 809.00K | 1.00M | ||||
| Investing Cash Flow | -72.00K | -8.00K | -298.00K | 791.00K | 1.00M | |
| Short-Term Debt Issued | 1.34M | 4.00M | ||||
| Long-Term Debt Issued | 1.05M | 1.00M | ||||
| Total Debt Issued | 20.00M | 1.34M | 1.05M | 1.00M | 4.00M | |
| Short-Term Debt Repaid | -1.34M | -3.03M | ||||
| Long-Term Debt Repaid | -3.70M | |||||
| Total Debt Repaid | -1.34M | -3.70M | -3.03M | |||
| Net Debt Issued (Repaid) | 20.00M | -2.65M | 1.00M | 969.00K | ||
| Issuance of Common Stock | 2.70M | 13.84M | 37.35M | 19.14M | 34.89M | |
| Repurchase of Common Stock | -887.00K | -3.19M | ||||
| Other Financing Activities | -2.31M | -2.04M | ||||
| Financing Cash Flow | 21.81M | 10.65M | 36.79M | 10.99M | -1.31M | 33.82M |
| Foreign Exchange Rate Adjustments | 1.15M | -667.00K | 225.00K | -113.00K | -189.00K | -680.00K |
| Miscellaneous Cash Flow Adjustments | 1.00K | 1.00K | ||||
| Net Cash Flow | 9.18M | -4.85M | 19.37M | -1.86M | -17.53M | 19.26M |
| Free Cash Flow | -13.78M | -14.83M | -17.65M | -12.74M | -16.84M | -14.89M |
| Free Cash Flow Margin | -3,994.78% | -4,633.75% | ||||
| Free Cash Flow Per Share | -0.88 | -1.03 | -10.98 | |||
| Levered Free Cash Flow | -19.77M | -10.21M | -15.62M | -5.61M | -22.40M | 6.11M |
| Unlevered Free Cash Flow | -19.10M | -10.10M | -15.21M | -5.30M | -22.26M | 6.39M |
| Free Cash Flow After Leases | -13.78M | -14.83M | -17.65M | -12.74M | -16.84M | -14.89M |
| Cash Interest Paid | 423.00K | 34.00K | 85.00K | 262.00K | ||
| Cash Income Tax Paid | 6.00K | 12.00K | 118.00K | |||
| Change in Working Capital | -4.48M | -5.68M | 63.00K | 3.35M | -328.00K | 5.57M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 13.85M | 17.07M | 5.19M | 2.51M | 4.20M | 78.43M |
| Enterprise Value | 19.15M | 1.56M | -11.94M | 3.97M | 3.34M | 72.98M |
| Last Close Price | 0.87 | 1.08 | 1.17 | 330.66 | 246,787.06 | 8,714,406.00 |
| PS Ratio | 40.14 | 53.33 | ||||
| PB Ratio | 3.92 | 1.74 | 0.44 | -0.91 | 2.22 | 4.17 |
| P/TBV Ratio | 3.92 | 1.74 | 0.44 | |||
| EV/Sales Ratio | 55.52 | 4.88 | ||||
| Debt / Equity Ratio | 6.30 | 0.14 | 0.11 | -0.47 | 1.98 | 0.06 |
| Net Debt / Equity Ratio | 1.50 | -1.36 | -1.55 | -0.39 | 0.88 | -1.00 |
| Net Debt / EBITDA Ratio | -0.49 | 1.06 | 1.04 | -0.06 | -0.10 | 0.71 |
| Net Debt / FCF Ratio | -0.39 | 0.90 | 1.03 | -0.09 | -0.10 | 1.27 |
| Asset Turnover | 0.01 | 0.02 | ||||
| Quick Ratio | 0.64 | 1.86 | 2.01 | 0.08 | 0.26 | 1.03 |
| Current Ratio | 1.11 | 2.13 | 2.06 | 0.14 | 0.44 | 1.03 |
| Return on Equity (ROE) | -157.09% | -103.80% | -541.17% | -155.34% | -123.30% | |
| Return on Assets (ROA) | -25.31% | -38.52% | -63.52% | -81.08% | -32.90% | -39.98% |
| Return on Capital Employed (ROCE) | -305.30% | -128.30% | -148.50% | 743.10% | -508.50% | -91.80% |
| Earnings Yield | -90.41% | -65.81% | -472.60% | -473.76% | -382.75% | -33.98% |
| FCF Yield | -99.52% | -86.89% | -340.25% | -507.36% | -401.27% | -18.98% |
| Buyback Yield / Dilution | -92.11% | -794.77% |